Lianhuan Pharmaceutical (600513.SH): The raw material drug product Levonorgestrel has passed the World Health Organization pre-certification site inspection.

Zhtng Cijng APP news, Lianhuan Pharmaceutical (600513.SH) announced that the company recently received a notification from the World Health Organization (WHO). The WHO pre-qualification team has completed the on-site inspection of the company's active pharmaceutical ingredient Levonorgestrel (APIMF484, WHOAPI-484), and the results are in compliance with the WHO's Good Manufacturing Practices (GMP) standards.